Search
Thursday 20 August 2015
  • :
  • :
Latest Update

Active Stocks Under Review: Etsy Inc (NASDAQ:ETSY), XL Group plc (NYSE:XL), Rentech, Inc. (NASDAQ:RTK), Illumina, Inc. (NASDAQ:ILMN)

On Tuesday, Shares of Etsy Inc (NASDAQ:ETSY), lost -8.59% to $15.86.

Etsy declared financial results for its second quarter 2015, ended June 30, 2015.

Second Quarter 2015 Operational Highlights

GMS was $546.2 million, up 24.6% contrast with the second quarter of 2014. Growth in GMS was driven by 24.6% year-over-year growth in active sellers and 31.6% year-over-year growth in active buyers. We continued to make progress in narrowing the gap between mobile visits and mobile GMS as a result of strong year-over-year GMS growth on our mobile app platform. Etsy has rapidly become a mobile-first company; percent mobile visits was about 60% contrast with about 53% in the second quarter of 2014 and percent mobile GMS was about 43% contrast with about 36% in the second quarter of 2014. Mobile visits also continued to grow faster than desktop visits.

We believe our GMS growth and percent international GMS are influenced by currency exchange rates in two ways. First, about 9% of our GMS comes from goods that are not listed in U.S. dollars and as a result is subject to the impact of currency exchange fluctuations. On a currency-neutral basis, GMS growth in the second quarter of 2015 would have been 26.5% or about 1.9 percentage points higher than the as-stated 24.6% growth.

Etsy, Inc. operates a marketplace where people connect, both online and offline, to make, sell and buy goods. The Company operates at the center of macroeconomic trends in online and mobile commerce, employment, consumption and manufacturing.

Shares of XL Group plc (NYSE:XL), declined -0.12% to $40.28, during its last trading session.

XL Group plc, declared that Claus-Michael “Michael” Dill has joined the Company’s Board of Directors.

Mr. Dill, a former board member of Catlin Group Limited, has close to three decades of experience in the insurance industry, counting holding senior positions at (re)insurance companies in Germany and Switzerland. Among his past roles are Chief Financial Officer of Vereinte Insurance AG in Munich, Chief Executive Officer of Switzerland General Insurance AG – both part of the Swiss Re Group, and Chief Executive Officer of AXA Konzern AG in Cologne and Executive Committee Member of AXA Group, Paris.

XL GROUP Public Limited Company, an insurance and reinsurance company, provides property, casualty, and specialty products to industrial, commercial, and professional firms; and insurance companies and other enterprises worldwide. The company operates in two segments: Insurance and Reinsurance.

At the end of Tuesday’s trade, Shares of Rentech, Inc. (NASDAQ:RTK), lost -0.16% to $0.731.

Rentech, declared financial and operating results for the three and six months ended June 30, 2015.

Keith Forman, President and CEO of Rentech, stated, “Our nitrogen business exceeded our expectations this quarter due to strong demand for ammonia and ammonium sulfate during the spring application season. Rentech Nitrogen declared a strong second quarter cash distribution and raised guidance for distributions in 2015, which will add to Rentech’s cash position.”

“Fulghum had a strong second quarter largely due to cost controls and improved performance in South America. We expect this segment to finish the year at the high end of our indicated range for EBITDA of $16 to $17 million. NEWP continues to perform well and the business is tracking to full year EBITDA guidance of $9 to $10 million,” said Mr. Forman.

Rentech, Inc., through its auxiliaries, provides wood fiber processing services, wood chips, and wood pellets. The company operates through five segments: East Dubuque; Pasadena; Fulghum Fibres; Wood Pellets: Industrial; and Wood Pellets: NEWP. It manufactures and sells natural-gas based nitrogen fertilizer products in North and South America.

Finally, Illumina, Inc. (NASDAQ:ILMN), ended its last trade with -0.44% loss, and closed at $207.00.

Illumina, Warburg Pincus and Sutter Hill Ventures, declared that they have formed a company to empower consumers to discover insights into their own genomes through a vibrant ecosystem of high-quality content partners. The company, called Helix, is based in the San Francisco Bay Area and received financing commitments in excess of $100 million. Jay Flatley, CEO of Illumina, will serve as Chairman of the Board.

Helix will enable individuals to acquire an unprecedented amount of genetic information by providing affordable sequencing and database services for consumer samples brought through third party partners, driving the creation of an ecosystem of consumer applications. After being sequenced, individuals will be able to manage their data and explore an open marketplace of on-demand applications, offered by Helix’s partners, to gain additional insights into the genomic data that has already been attained. By converting genetic information to digital data stored in the cloud, Helix enables its partners to develop and deliver premium genomic products to consumers without the burden of developing their own assay, laboratory, or database infrastructure.

“Genomics is reaching an inflection point in cost, volumes, and knowledge, creating a noteworthy opportunity to unlock information that is presently not widely accessible to individuals,” said Flatley. “Helix and its founding investors are committed to creating a neutral platform at the highest quality standard that will work with partners to accelerate consumer adoption of genomics.”

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products comprise sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms comprise of HiScan and iScan systems, in addition to NextSeq 550 system that are array scanners for DNA and RNA analysis applications, counting single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified using such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *